netFormulary
 Report : A-Z NHS England items in Formulary 04/07/2020 04:14:49
[Back]
 
Section Status NHS England Name
03.04.03 Restricted Use MHS England C1 Esterase Inhibitor Berinert
04.08.01 Restricted Use MHS England Cannabidiol Epidyolex
08.01.05 Restricted Use MHS England Dacomitinib Vizimpro
03.04.03 Restricted Use MHS England Lanadelumab  Takhzyro®
08.03.04.03 Restricted Use MHS England Lanreotide Somatuline Autogel
08.03.04.03 Formulary MHS England Lanreotide 30mg Somatuline LA
08.01.05 Restricted Use MHS England Larotrectinib  Vitrakvi
05.03 Restricted Use MHS England Letermovir Prevymis®
08.01.05 Restricted Use MHS England Neratinib Nerlynx
08.03.04.03 Restricted Use MHS England Octreotide Sandostatin Lar
08.03.04.03 Formulary MHS England Octreotide 50mcg, 100mcg, 500mcg Sandostatin
03.05.02 Restricted Use MHS England Poractant Alfa 120mg/1.5mL, 240mg/3mL Curosurf
Bedfordshire and Luton Joint Formulary